| Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ... Ep Europace 17 (10), 1467-1507, 2015 | 1463 | 2015 |
| Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study TB Larsen, LH Rasmussen, F Skjøth, KM Due, T Callréus, M Rosenzweig, ... Journal of the American College of Cardiology 61 (22), 2264-2273, 2013 | 569 | 2013 |
| Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study TB Larsen, F Skjøth, PB Nielsen, JN Kjældgaard, GYH Lip bmj 353, 2016 | 517 | 2016 |
| Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation GYH Lip, TB Larsen, F Skjøth, LH Rasmussen Journal of the American College of Cardiology 60 (8), 738-746, 2012 | 408 | 2012 |
| Classification of myocardial infarction: frequency and features of type 2 myocardial infarction L Saaby, TS Poulsen, S Hosbond, TB Larsen, ACP Diederichsen, J Hallas, ... The American journal of medicine 126 (9), 789-797, 2013 | 389 | 2013 |
| Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study PB Nielsen, F Skjøth, M Søgaard, JN Kjældgaard, GYH Lip, TB Larsen bmj 356, 2017 | 387 | 2017 |
| Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study TB Larsen, HT Sørensen, M Gislum, SP Johnsen Thrombosis research 120 (4), 505-509, 2007 | 356 | 2007 |
| Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation L Melgaard, A Gorst-Rasmussen, DA Lane, LH Rasmussen, TB Larsen, ... Jama 314 (10), 1030-1038, 2015 | 334 | 2015 |
| Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care DA Lane, F Skjøth, GYH Lip, TB Larsen, D Kotecha Journal of the American Heart Association 6 (5), e005155, 2017 | 291 | 2017 |
| Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide … PB Nielsen, TB Larsen, F Skjøth, A Gorst-Rasmussen, LH Rasmussen, ... Circulation 132 (6), 517-525, 2015 | 284 | 2015 |
| Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score GYH Lip, F Skjøth, LH Rasmussen, TB Larsen Journal of the American College of Cardiology 65 (14), 1385-1394, 2015 | 212 | 2015 |
| Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc? PB Nielsen, F Skjøth, TF Overvad, TB Larsen, GYH Lip Circulation 137 (8), 832-840, 2018 | 201 | 2018 |
| Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort L Saaby, TS Poulsen, ACP Diederichsen, S Hosbond, TB Larsen, ... The American journal of medicine 127 (4), 295-302, 2014 | 198 | 2014 |
| Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study A Gorst‐Rasmussen, F Skjøth, TB Larsen, LH Rasmussen, GYH Lip, ... Journal of Thrombosis and Haemostasis 13 (4), 495-504, 2015 | 189 | 2015 |
| Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis LH Rasmussen, TB Larsen, T Graungaard, F Skjøth, GYH Lip Bmj 345, 2012 | 175 | 2012 |
| Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins TB Larsen, HT Sørensen, A Skytthe, SP Johnsen, JW Vaupel, ... Epidemiology 14 (3), 328-332, 2003 | 165 | 2003 |
| Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation TB Larsen, A Gorst-Rasmussen, LH Rasmussen, F Skjøth, M Rosenzweig, ... The American journal of medicine 127 (7), 650-656. e5, 2014 | 152 | 2014 |
| European Heart rhythm association (EHRA)/European association of cardiovascular prevention and rehabilitation (EACPR) position paper on how to prevent atrial fibrillation … EP Europace 19 (2), 190-225, 2017 | 151 | 2017 |
| Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin IE Albertsen, LH Rasmussen, TF Overvad, T Graungaard, TB Larsen, ... Stroke, 2013 | 150 | 2013 |
| Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European heart rhythm association (EHRA) and European … GYH Lip, JP Collet, R Caterina, L Fauchier, DA Lane, TB Larsen, F Marin, ... Ep Europace 19 (11), 1757-1758, 2017 | 149 | 2017 |
Flemming SkjøthAalborg University HospitalVerified email at rn.dk
